In Depth 1 Feb 2023
Cancer: what are the barriers to research?
Everyone imagines a world without cancer, but getting there is difficult. With World Cancer Day coming up on February 4,…
ISA Pharmaceuticals
- Latest Posts
In Depth 1 Feb 2023
What will cancer therapy look like in 2033?
For our special newsletter on cancer, Labiotech had the opportunity to put the same question to several biotech company experts. And…
In Depth 1 Feb 2023
How can cancer care be improved?
Labiotech recently asked several biotech experts the same question about tackling cancer, for a special newsletter to commemorate World Cancer…
News and Trends 1 Dec 2022
Trial for HPV16 positive oropharyngeal cancer completes enrolment for phase 2
Netherlands-based ISA Pharmaceuticals B.V., has announced that it has completed enrolment in its phase 2 clinical trial. Named OpcemISA. The…
ADVERTISEMENT
More News! 8 Nov 2022
ISA Pharmaceuticals’ Amplivant adjuvant boosts immune response in SLP immunotherapy
ISA Pharmaceuticals B.V, a Netherlands-based clinical stage biotech developing immunotherapies to treat cancers and infectious diseases has had a phase…
News and Trends 18 Dec 2017
Dutch and US Biotechs Team Up Against HPV-related Cancer
ISA Pharmaceuticals will work together with Regeneron to combine its immunotherapy against cancer induced by HPV infection with its partner's…
Best in Biotech 28 Feb 2017
Stroopwaffels, Krokets and Biotechs – Meet the Top 10 in Leiden!
Known for its charming canals and tulip fields, Leiden is a major tourist attraction in the Netherlands. It is also home…
News and Trends 1 Dec 2016
7 European Institutions in the Largest Cancer Bioinformatics Collaboration
Europe's best companies using bioinformatics to tackle cancer will take part in a huge collaboration aimed at developing personalized cancer…
News and Trends 29 Sep 2016
Debunking the Immuno-Oncology Hype: is it as good as it sounds?
CAR-T therapies have gained plenty of attention lately by promising to end cancer with a one-off treatment. But all that glitters…
News and Trends 11 Mar 2016
Reviewing Immuno-Oncology: What works and what doesn’t
Researchers from Leiden University Medical Center (LUMC) and ISA Pharmaceuticals (Netherlands) have authored an extensive review of what is working in…